Previous close | 1,728.50 |
Open | 1,733.00 |
Bid | 1,650.00 x 0 |
Ask | 1,749.00 x 0 |
Day's range | 1,718.00 - 1,743.00 |
52-week range | 1,302.60 - 1,743.00 |
Volume | |
Avg. volume | 8,167,807 |
Market cap | 70.692B |
Beta (5Y monthly) | 0.27 |
PE ratio (TTM) | 15.90 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.60 (3.46%) |
Ex-dividend date | 16 May 2024 |
1y target est | N/A |
GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
Glaxo (GSK) delivered earnings and revenue surprises of 15.96% and 3.99%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?